IRIS
CRISCUOLO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 325
NA - Nord America 280
AS - Asia 31
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 280
SE - Svezia 188
IT - Italia 101
CN - Cina 18
FI - Finlandia 13
IE - Irlanda 9
RU - Federazione Russa 5
SG - Singapore 5
DE - Germania 4
IN - India 4
AU - Australia 3
A1 - Anonimo 2
HK - Hong Kong 2
PL - Polonia 2
BR - Brasile 1
EU - Europa 1
FR - Francia 1
GB - Regno Unito 1
KR - Corea 1
PH - Filippine 1
RO - Romania 1
ZA - Sudafrica 1
Totale 644
Salva come PNG Salva come JPEG
Città #
Ashburn 75
Milan 63
Princeton 39
Lawrence 38
New York 26
Helsinki 13
Shanghai 12
Dublin 9
Rome 6
Ancona 4
Pune 4
Turin 4
Washington 4
Bologna 3
Busto Arsizio 3
Council Bluffs 3
Los Angeles 3
Magnago 3
Melbourne 3
Bergamo 2
Como 2
Gatchina 2
Kunming 2
Kwai Chung 2
Las Vegas 2
Santa Clara 2
Seattle 2
Segrate 2
Bacoor 1
Bari 1
Beijing 1
Bloemfontein 1
Borås 1
Frankfurt am Main 1
Guangzhou 1
Houston 1
Lansing 1
London 1
Omsk 1
Redwood City 1
Rockville 1
San Diego 1
Shenzhen 1
St Petersburg 1
São Paulo 1
Vimodrone 1
Volgograd 1
Totale 352
Salva come PNG Salva come JPEG
Nome #
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 35
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 30
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 27
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 25
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 25
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 23
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 22
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 21
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 19
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 19
Evaluation of synergistic interactions of anti-HCV/E2 monoclonal antibodies 19
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 19
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 18
Bacteriophages and Their Immunological Applications against Infectious Threats 18
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 18
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 18
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 17
Viral Respiratory Pathogens and Lung Injury 17
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 17
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 17
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 16
The initial interplay between HIV and mucosal innate immunity 16
The interferon landscape along the respiratory tract impacts the severity of COVID-19 16
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 15
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 15
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 15
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 15
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 15
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 15
Phage Therapy: An Alternative to Antibiotics 14
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 14
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 14
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 14
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 13
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 13
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 12
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 12
Role and potential therapeutic use of antibodies against herpetic infections 12
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 12
Next Generation Vaccines for Infectious Diseases 12
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 11
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 10
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 10
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 9
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 9
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 7
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 4
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases 3
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 3
null 1
Totale 771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 5 0 0 0 0 0 6 0 0 0 0 1
2020/202113 2 0 0 2 4 0 2 0 0 3 0 0
2021/202284 6 3 10 10 13 7 9 2 2 9 0 13
2022/2023356 89 78 49 7 3 41 33 30 15 2 8 1
2023/2024263 1 20 42 62 19 62 9 25 13 8 2 0
Totale 771